LA500 BLUE LIGHT

K033201 · Apoza Enterprise Co., Ltd. · EBZ · Dec 2, 2003 · Dental

Device Facts

Record IDK033201
Device NameLA500 BLUE LIGHT
ApplicantApoza Enterprise Co., Ltd.
Product CodeEBZ · Dental
Decision DateDec 2, 2003
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.6070
Device ClassClass 2
AttributesTherapeutic

Intended Use

The intended use of the LA500 Blue Light is for the polymerization of light cure material and activation of dental bleaching materials.

Device Story

LA500 Blue Light is a dental curing unit used by dental professionals to polymerize light-cured materials and activate bleaching agents. Device emits blue light to initiate chemical curing processes in dental restorative materials. Operated by dentists or dental staff in clinical settings. Provides controlled light output to ensure proper material hardening or activation. Benefits include efficient, reliable curing of dental materials, facilitating restorative and cosmetic dental procedures.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Visible light curing unit. Emits blue light for polymerization and activation. Class II device under 21 CFR 872.6070. Product code EBZ.

Indications for Use

Indicated for polymerization of light-cured dental materials and activation of dental bleaching materials by dental professionals.

Regulatory Classification

Identification

An ultraviolet activator for polymerization is a device that produces ultraviolet radiation intended to polymerize (set) resinous dental pit and fissure sealants or restorative materials by transmission of light through a rod.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # 5. 510(K) SUMMARY DEC - 2 2003 ● . � ● APOZA CURING LIGHT, Models: LA500 Blue Light 510K: - APOZA ENTERPRISE CO., LTD. Submitted by: 6F, No.657, Chuang Cheng Road, Hsin-Chuang City, Taipei Hsien, China (Taiwan) Contact person: Mr. Shih, Min-Teh Apoza Enterprise Co., Ltd. 6F, No.657, Chuang Cheng Road, Hsin-Chuang City, Taipei Hsien, China (Taiwan) - Date Summary Prepared: September 27, 2003 . - Classification name: Activator, Ultraviolet, for Polymerization - Classification number: EBZ, Class II - . Regulation Number: 872.6070 - Proprietary name: APOZA CURING LIGHT, LA500 Blue Light - Common name of device: . CURING LIGHT - . Predicate Device: Kerr Corporation Optilux 501 510K No - K020091 {1}------------------------------------------------ ## Statement of Intended Use: APOZA CURING LIGHT, LA500 Blue Light The intended use of the LA500 Blue Light is for the polymerization of light cure material and activation of dental bleaching materials. ## Comparison to Predicate Devices: The APOZA CURING LIGHT, LA500 Blue Light, have been carefully compared to legally marketed devices with respect to intended use and technological characteristics. In addition, performance testing has been done to validate the performance of the device. The comparison and validation results presented in this 510k notification to the FDA show that the subject device is substantially equivalent to predicated device and is safe and effective in its intended use. We believe that the APOZA CURING LIGHT, LA500 Blue Light is substantially equivalent to the predicate device, i.e., KERR CORPORATION OPTILUX 501 in K.020091, and the data provided support the safety and effectiveness of LA500 for the intended uses. {2}------------------------------------------------ Public Health Service DEC - 2 2003 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Min-Teh Shih General Manager Apoza Enterprise Company, LTD 6F, 657, Chung-Cheng Road Hsin-Chuang City, Taipei Hsicn, 242 Taiwan, CHINA Re: K033201 Trade/Device Name: LA500 Blue Light Regulation Number: 21 CFR 872.6070 Regulation Name: Ultraviolet Activator for Polymerization Regulatory Class: II Product Code: EBZ Dated: September 27, 2003 Received: October 02, 2003 Dear Mr. Shih: We have reviewed your Section 510(k) premarket notification of intent to market the device We have reviewed your Section 3 l'0(x) premails. In anywards (tfor the indications for referenced above and have determilied the increase devices marketed in interstate commerce use stated in the enclosure) to legally marketed pedical a mandments, or to devices use stated in the enclosure) to legally filation products and mentments, or to devices that prior to May 28, 1976, the enacthem date of the Federal Food, Drug, and Cosmetic have been reclassified in accordance with the provisions of the Federal Food, You may. have been reclassified in accordance with the provisions wal application (PMA). You may, Act (Act) that do not require approval of a premarks approval application of the Act Act (Act) that do not require approval of a prematiconspissions of the Act. The general therefore, market the device, subject to the general controls provisions of the Act. T therefore, market the device, subject to the generation, list negativation, listing of devices, good controls provisions of the Act include requirements for any adulteration. controls provisions of the Act mende requirements for and adulteration. manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (see above) into Euro regulations affecting your device can be may be subject to such additional controls. Existing mayor regulations FDA may may be subject to such additional controls. 1:21stilly nagor 89% In addition, FDA may publish found in the Code of Federal Regulations, Title 21, Parts 800 to 89% In addi found in the Code of I cacral regginations, which in the Federal Register. {3}------------------------------------------------ ### Page 2 - Mr. Min-Teh Shih Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21. CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely vours. non Chiu S. Lin, PhD Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # 4. INDICATIONS FOR USE STATEMENT | Applicant : | APOZA Enternrise Co<br>I to | | |-----------------|-----------------------------|--| | 510(k) Number : | TO DE . | | Device Name : APOZA CURING LIGHT, LA500 Blue Light Indications for Use : LA500 Blue Light is a visible curing unit programmed for This polymerization of light cured materials by dental professionals.. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH Office of Device Evaluation (ODE) Prescription Use Per 21 CFR 801.109 OR Over-The-Counter (Optional Format 1-2-96) General Hospital. Infection Control, Dental 510(k) Number:_
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from the tree

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...